Form EFFECT RedHill Biopharma Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 5, 2026 |
| Accession Number: | 0001178913-26-002360 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northisle Announces Drill Results at Red Dog Identify Emerging High-Grade Trend in Eastern Portion of Deposit
- SES to conduct share buyback transaction via acquisition of FDRs to meet obligations under its employee incentive programs
- Dimensional Fund Advisors Ltd. : Form 8.3 - DCC PLC - Ordinary Shares
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
